Although several novel biomarkers for detecting kidney injury and predicting AKI development—such as NGAL, KIM-1, cystatin C, and IL-18—have been discovered, they are still insufficiently sensitive for early detection, which makes the exploration of early prediction of SA-AKI irreplaceable (5). This evidence concerns the gene LCN2 and acute kidney injury.